Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

MediNatura to purchase Heel Group's USA operation

MediNatura™ Incorporated, a Delaware Corporation headquartered in greater Philadelphia, today announced an agreement to purchase the Heel Group's USA operations, which is expected to be completed in late August 2014.

31 May 2014

Vitamix Laboratories opens new manufacturing facility in Commack, New York

Vitamix Laboratories, one of the most highly regarded vitamin manufacturers in the industry, recently announced a major milestone: the company has moved into a new 23,175 square foot state-of-the-art manufacturing facility in Commack, New York.

31 May 2014

Research report on sports nutrition market in Europe

Sports Nutrition Market in Europe 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts.

31 May 2014

TPP wins $500,000 grant from Biogen Idec to help students start and run own businesses

The Biogen Idec Foundation has awarded a $500,000 grant to The Possible Project (TPP), a non-profit organization that teaches high school students how to start and run their own businesses through a tailored curriculum, and access to technology and to mentors from the local business community.

29 May 2014

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

Patrys Limited, a clinical stage biotechnology company, is pleased to announce the clinical results from a patient treated with PAT-SM6 in combination with other marketed multiple myeloma drugs.

28 May 2014

BioTime receives ISO 13485:2003 certification for development of BioTime HyStem hydrogels

BioTime, Inc. today announced that it has received ISO 13485:2003 certification from BSI (British Standards Institution) for design, development, manufacture, and distribution of BioTime HyStem® hydrogels for cell delivery applications.

28 May 2014

Polyplus-transfection introduces FectoPRO transfection reagent

Polyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO, the latest optimised transfection reagent in their product portfolio. FectoPRO has been designed for high yields in medium and large-scale production of proteins and antibodies in mammalian cells.

28 May 2014

Scientists collect new data on how "tumor suppressor" gene works

Scientists armed with a supercomputer and a vast trove of newly collected data on the body's most potent "tumor suppressor" gene have created the best map yet of how the gene works, an accomplishment that could lead to new techniques for fighting cancers, which are adept at disabling the gene in order to thrive.

28 May 2014

Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

A drug's half-life indicates how long a substance will remain active in the body. It is essentially the period of time that it takes for the concentration of the amount of the drug to be reduced by half, and therefore, determines how frequently a drug needs to be administered to maintain its therapeutic effect.

27 May 2014

Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Twist Bioscience today announced that it raised $26 million in a Series B financing to commercialize the company's semiconductor-based synthetic gene manufacturing process.

27 May 2014

Research report on medical waste management market

MRRBIZ includes new market research report "Medical Waste Management Market (Activity Type - Collection, Processing And Disposal; Waste Generators - Large Quantity Generators And Small Quantity Generators) Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its large collection of research report.

27 May 2014

New report raises important questions about transcranial direct current stimulation

Over the past several decades, neurostimulation techniques such as transcranial direct current stimulation (tDCS) have gradually gained favour in the public eye. In a new report, published yesterday in the prestigious scientific journal Neuron, IRCM ethics experts raise important questions about the rising tide of tDCS coverage in the media, while regulatory action is lacking and ethical issues need to be addressed.

23 May 2014

Neovasc reports record revenues in Q1 2014

Neovasc Inc. ("Neovasc" or the "Company"), today announced financial results for the three months ended March 31, 2014. "The first quarter of 2014 was marked by major developments at Neovasc," noted Alexei Marko, chief executive officer of Neovasc.

22 May 2014

New 5-layer flask enhances cell culture production

Porvair Sciences has announced a new 5-layer cell culture flask developed to fulfil the need of the growing number of applications that require large numbers of cells.

From Chromatrap® - Porvair Sciences Ltd 22 May 2014

Leica Microsystems and Med X Change announce select Leica surgical microscopes are now available with integrated 1080p recording

Leica Microsystems and Med X Change announce that select Leica surgical microscopes are now available with integrated 1080p video recording and still image capture. The compact Med X Change EvolutionHD 2D Medical Video Recorder, EVO for short, seamlessly integrates with the microscope stands, providing high definition video recording without interrupting surgical workflow. This small, powerful, high end medical video recorder with state-of-the-art features delivers surgical content automatically to Apple® iPad and iPhone mobile devices. Leica Microsystems presented the system at the American Society of Cataract and Refractive Surgery / American Society of Ophthalmic Administrators Symposium & Congress, April 25-29, 2014, in Boston, MA, USA.

20 May 2014

BioLineRx announces financial results for Q1 2014, provides operational update

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.

20 May 2014

Existing pharmaceutical drugs may offer effective therapies against MERS

A series of research articles published ahead of print in the journal Antimicrobial Agents and Chemotherapy have identified a number of existing pharmaceutical drugs and compounds under development that may offer effective therapies against Middle East Respiratory Syndrome (MERS).

20 May 2014

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

RNA interference (RNAi) is a naturally occurring process, which cells can use to silence, or ‘turn off’ unwanted genes.

From Quest Diagnostics 19 May 2014

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Following a May 15, 2014, meeting with the U.S. Food and Drug Administration (FDA), Shire plc, the global specialty biopharmaceutical company, announces today that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as we complete remaining chemistry and manufacturing work.

19 May 2014

Bio-Path Holdings reports net loss of $504,876 for first quarter 2014

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the first quarter ended March 31, 2014.

17 May 2014

Manufacturing News and Research

Further Reading

MediNatura to purchase Heel Group's USA operation

Vitamix Laboratories opens new manufacturing facility in Commack, New York

Research report on sports nutrition market in Europe

TPP wins $500,000 grant from Biogen Idec to help students start and run own businesses

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

BioTime receives ISO 13485:2003 certification for development of BioTime HyStem hydrogels

Polyplus-transfection introduces FectoPRO transfection reagent

Scientists collect new data on how "tumor suppressor" gene works

Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Research report on medical waste management market

New report raises important questions about transcranial direct current stimulation

Neovasc reports record revenues in Q1 2014

New 5-layer flask enhances cell culture production

Leica Microsystems and Med X Change announce select Leica surgical microscopes are now available with integrated 1080p recording

BioLineRx announces financial results for Q1 2014, provides operational update

Existing pharmaceutical drugs may offer effective therapies against MERS

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Bio-Path Holdings reports net loss of $504,876 for first quarter 2014

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News